AGC Biologics and Evax Partner to Advance Promising Equine Allergy Vaccine Candidate
September 07, 2022 17:00 ET
|
AGC Biologics
Seattle, Sept. 07, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a new partnership with Evax,...